Financials
- Market Capitalization 400.55 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
3.68
売上高対価格比率
35.88
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3050 | LRMR Larimar Therapeutics, Inc. - Common Stock | 4.01 USD | -0.99% | -5.20% | +4.70% | +9.56% | 416.57 M USD | ||
| 3069 | GALT Galectin Therapeutics Inc. - Common Stock | 4.02 USD | -2.90% | +9.24% | +35.35% | -6.07% | 405.42 M USD | ||
| 3079 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.86 USD | -2.61% | -0.41% | +17.11% | +1.89% | 398.74 M USD | ||
| 3085 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.60 USD | -1.45% | +1.19% | +7.09% | +56.32% | 396.11 M USD |